(JA) Osono T, Yano K, Mitamoto F, Watanabe S, Ishida H, [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities], in Jpn J Antibiot, vol. 22, n. 2, aprile 1969, pp. 159–72, PMID 4389777.
(DE) Wildfeuer A, Lemme JD, [The pharmacokinetics of josamycin], in Arzneimittelforschung, vol. 35, n. 3, 1985, pp. 639–43, PMID 4039591.
Fraschini F, Braga PC, Gagliardi V, et al., [Pharmacokinetics of josamycin in man and distribution in various compartments], in G Ital Chemioter, 29 Suppl 1, 1982, pp. 69–76, PMID 6927123.
(JA) Tachibana A, Sasaki H, Watanabe T, Yano K, Sado T, [Absorption, distribution and excretion of 14C-josamycin and 14C-josamycin propionate in rats (author's transl)], in Jpn J Antibiot, vol. 28, n. 4, agosto 1975, pp. 558–66, PMID 1160146.
(JA) Kobayashi Y, Akaishi K, Nishio T, Aihara M, [Josamycin propionate in the treatment of acute respiratory infections in children], in Jpn J Antibiot, vol. 26, n. 3, giugno 1973, pp. 267–76, PMID 4542549.
(RU) Iakovlev SV, Aleksandrova MA, Suvorova MP, Kostina SA, [Evaluation of efficacy and safety of josamycin (Vilprafen) in the treatment of patients with community-acquired pneumonia], in Antibiot. Khimioter., vol. 51, n. 3-4, 2006, pp. 47–8, 50–2, PMID 17165259.
(DE) Kerschbaum H, Moritz AJ, [Josamycin in bronchopulmonary and otorhinological diseases in pediatrics], in Padiatr Padol, vol. 18, n. 4, 1983, pp. 403–8, PMID 6646791.
(FR) Lagarrigue J, [Josamycin in oral-dental infections], in Chir Dent Fr, vol. 52, n. 159, maggio 1982, pp. 35–8, PMID 6961989.
Beltrame M, Dazzi P, Baldin C, Musola L, [Use of josamycin in infections of the oral cavity], in Dent Cadmos, vol. 52, n. 12, dicembre 1984, pp. 115, 119–20, 122, PMID 6598783.
(HU) Kiss Z, [Experiences with josamycin therapy in dermatologic diseases], in Orv Hetil, vol. 141, n. 19, maggio 2000, pp. 1015–7, PMID 10846423.
(JA) Nohara N, Akagi O, Kanzaki H, et al., [Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method], in Kansenshōgaku Zasshi, vol. 63, n. 3, marzo 1989, pp. 203–27, PMID 2504834.
Bartolotta G, Amico F, Siragusa A, [Josamycin in urologic infections], in G Ital Chemioter, 29 Suppl 1, 1982, pp. 175–80, PMID 6927115.
Lazzaro A, Vettori G, Bagozzi B, [Clinical use of josamycin in comparison with erythromycin in respiratory and urinary tract infections], in Clin Ter, vol. 114, n. 6, settembre 1985, pp. 469–73, PMID 3905221.
Torre D, Maggiolo F, Sampietro C, Comparative clinical study of josamycin and erythromycin in pertussis, in Chemioterapia, vol. 3, n. 4, agosto 1984, pp. 255–7, PMID 6099755.
Freymond N, Catelain A, Cousin F, Nicolas JF, Skin delayed-type hypersensitivity to josamycin, in Allergy, vol. 58, n. 12, dicembre 2003, pp. 1319–20, PMID 14616115.
(JA) Shigematsu T, Oi M, Kawamoto T, Konnai T, Takeyasu K, [Clinical experiments in the use of a macrolide antibiotic, Josamycin and its effects on the liver], in Shikwa Gakuho, vol. 71, n. 2, febbraio 1971, pp. 703–7, PMID 5279686.
(ES) Lavín I, Mundi JL, Trillo C, et al., [Cholestatic hepatitis by josamycin], in Gastroenterol Hepatol, vol. 22, n. 3, marzo 1999, p. 160, PMID 10228329.
(FR) Grolleau JY, Martin M, de la Guerrande BD, Barrier J, Peltier P, [Acute ergotism with a therapeutic association josamycin/ergotamine (author's transl)], in Therapie, vol. 36, n. 3, 1981, pp. 319–21, PMID 7292409.
Pessayre D, Effects of macrolide antibiotics on drug metabolism in rats and in humans, in Int J Clin Pharmacol Res, vol. 3, n. 6, 1983, pp. 449–58, PMID 6381341.
